department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Biofrontera Inc. ($BFRI) · pharmadog

PUBLIC COMPANY

$BFRIBiofrontera Inc.

Woburn, MA, USupdated 1mo ago

SEC EDGAR ↗Yahoo Finance ↗

community read0 votes

pipeline

1

marketed

1

phase 3

0

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(1)

pipeline depth1 products

1Marketed

aminolevulinic acid hydrochloride

Basal Cell Carcinoma (Basal Cell Epithelioma)

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Biofrontera Inc. jobs →

News

no news has mentioned this company yet

identifiers

ticker

$BFRI

SEC CIK

0001858685

country

US

source

sec_tickers

top tags

Dermatology1 Oncology1

mentioned in

0news items

entity-linker matched

$BFRI

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Insider activity

source: SEC Form 4

routine RSU / option mechanics (6)

Mar 5, 26option exerciseLuebbert Hermann · CEO & Chairman137,500 sh
Mar 5, 26option exerciseLuebbert Hermann · CEO & Chairman137,500 sh
Mar 5, 26option exerciseLeffler Eugene Frederick · Chief Financial Officer87,500 sh
Mar 5, 26option exerciseLeffler Eugene Frederick · Chief Financial Officer87,500 sh
Mar 4, 26grantWeber Kevin Daniel · 20,000 sh
Mar 4, 26grantLuebbert Hermann · CEO & Chairman125,000 sh

Data sources

last refreshed 8m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Active trials

phase3Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lampactive not recruitingn=172
phase3Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).active not recruitingn=187
phase2Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adultsactive not recruitingn=126